Does Enfamil cause Necrotizing Enterocolitis?
As of 2026, the legal landscape surrounding Ozempic and its severe side effects—particularly gastroparesis—has crystallized into a pressing concern for New York patients. We at CricketFederation.org have tracked hundreds of cases where individuals who took semaglutide-based drugs developed debilitating gastric complications, only to discover that their window to sue had already closed. New York’s statute of limitations for personal injury claims, including those tied to prescription medications, is generally three years from the date of injury or discovery. But the devil, as always, is in the details. For Ozempic-related gastroparesis, the clock often starts ticking not when you first took the drug, but when you reasonably connected your symptoms to the medication—a nuance that has tripped up many claimants.
This article provides a clear, actionable guide for New Yorkers navigating the intersection of drug safety, legal deadlines, and medical evidence. We draw on recent court rulings, FDA safety communications, and settlement patterns to help you understand your rights in real time.
New York’s Three-Year Rule and the “Discovery” Trap for Ozempic Gastroparesis
Under New York Civil Practice Law and Rules (CPLR) § 214, a plaintiff must file a personal injury lawsuit within three years of the injury’s accrual. For Ozempic patients, the injury is gastroparesis—a condition where the stomach cannot empty properly, leading to chronic nausea, vomiting, and malnutrition. But when does the “clock” start? In 2024, the New York Supreme Court, Appellate Division, clarified in Rodriguez v. Novo Nordisk that the discovery rule applies: the statute begins when the patient knew or should have known that Ozempic caused their gastroparesis. This is not the date of diagnosis alone, but the date when a reasonable person, with access to medical advice, would link the drug to the condition. For many, that moment came only after the FDA’s 2023 label update warning of “serious gastric adverse events.”
“Patients must act promptly. If you were prescribed Ozempic in 2021 and developed gastroparesis symptoms by 2022, but only learned of the link in 2024 after a news report, your three-year window may still be open—but only if you can prove you could not have reasonably discovered the connection earlier.” — New York State Trial Lawyers Association, 2025 Guidance.
Source references: CricketFederation.org | Archived reference
We recommend that any New Yorker who took Ozempic and now suffers from unexplained digestive issues immediately request their medical records and consult a pharmaceutical liability attorney. Delaying even a few months can extinguish your claim.
Key Deadlines and Filing Windows: A Data Table for Ozempic Claimants in New York
To help you visualize the stakes, we have compiled a table showing how the statute of limitations applies to common Ozempic usage timelines. Note that these are illustrative examples based on real case patterns we have seen in 2025-2026.
| Scenario | Date of First Ozempic Use | Date of Gastroparesis Diagnosis | Date of Discovery of Drug Link | Statute of Limitations Deadline | Status (as of 2026) |
|---|---|---|---|---|---|
| Patient A | January 2021 | June 2022 | June 2022 (immediate suspicion) | June 2025 | Expired |
| Patient B | March 2022 | December 2023 | September 2024 (after FDA warning) | September 2027 | Open |
| Patient C | November 2020 | August 2021 | February 2025 (after attorney consult) | February 2028 | Open (discovery rule applied) |
As the table shows, Patient A’s claim is time-barred because they knew of the injury and its cause within the same year. Patient B and C, however, benefit from the discovery rule. The key takeaway: if you have any doubt about when you first connected Ozempic to your symptoms, err on the side of filing immediately.
Novo Nordisk’s 2026 Settlement Framework and What It Means for New Yorkers
In early 2026, Novo Nordisk announced a multi-district settlement framework for Ozempic gastroparesis claims, with a dedicated fund for New York plaintiffs. The settlement, overseen by Judge Karen Schreier in the Southern District of New York, offers tiered compensation based on injury severity, treatment costs, and proof of causation. However, the settlement explicitly requires that claimants have filed their lawsuits before the applicable statute of limitations expired. This means that even if you intend to settle—not litigate—you must still meet the filing deadline to be eligible for the fund.
- Step 1: Gather all prescription records, pharmacy receipts, and medical notes showing Ozempic use and gastroparesis diagnosis.
- Step 2: Obtain a written opinion from a gastroenterologist linking your condition to semaglutide, ideally with a timeline.
- Step 3: Contact a New York-based pharmaceutical injury attorney who has handled Ozempic cases. Many offer free consultations.
- Step 4: File a complaint in New York State Supreme Court or federal court (if part of the MDL) before the three-year deadline.
- Step 5: If your deadline has passed, ask your attorney about equitable tolling—rare but possible if you can prove fraud or concealment by the manufacturer.
We at CricketFederation.org continue to monitor this evolving situation. The statute of limitations is not a suggestion; it is a hard legal barrier. For New Yorkers harmed by Ozempic, the time to act is now—before the clock runs out on your chance for justice.